India gynecology and women’s healthcare market & digital opportunity

Women’s healthcare spans life stages, care settings and very different business models.

General gynecology, pregnancy care, fertility services, PCOS management and menopause support serve different needs. A local consultation practice, a maternity hospital and an IVF laboratory cannot be evaluated using the same revenue-per-patient or capacity assumptions.

World Bank population data place India’s female population at approximately 702.6 million in 2024 and 709.1 million in 2025. This includes girls and women of all ages; it is a demographic context, not the number of potential private-clinic customers. [1]

For independent practices, a practical digital opportunity is to make qualifications, service scope, fees, location and appointment access clear. For maternity and fertility centres, the same foundation must support longer decision journeys, explicit package inclusions and careful handling of sensitive enquiries.

How to read this report: source observations are dated and linked. Commercial market estimates retain their publisher attribution. Clinic and advertising tables are illustrative calculations, with assumptions shown; they are not national averages or promised returns.

Separate demographic need, observed service use and commercial market estimates.

The 2026 release of NFHS-6 provides a newer maternity baseline than NFHS-5. Institutional deliveries rose from 88.6% to 90.6%, while mothers receiving at least four antenatal visits increased from 58.5% to 65.2%. The comparison is between the 2019–21 and 2023–24 surveys, not annual clinic activity in 2026. [2]

TechSci Research estimates India’s IVF market at US$961.21 million in 2024 and forecasts US$1,491.85 million by 2030, with a stated 7.8% CAGR. These are publisher estimates within its defined market. They do not establish the total revenue of gynecology, maternity, diagnostics and women’s health products combined. [5]

A service-market model should specify what is billed, which providers receive it and whether diagnostic, pharmaceutical or hospital revenue is included. Adding overlapping product and clinical-service estimates creates a misleading total. A combined revenue figure requires a consistent scope and evidence for each component.

Count practitioners, clinic locations and regulated facilities separately.

FOGSI’s published historical message reports 39,607 members in December 2022. Professional-association membership is useful context, but it cannot establish how many specialists currently practise, their working hours or how many locations they cover. [3] Likewise, postgraduate seats measure training capacity rather than the stock of active doctors.

The Department of Health Research’s National ART & Surrogacy Registry records ART clinics, banks and surrogacy clinics. These are distinct categories. An application, registration, branch listing and operating IVF laboratory should not automatically be counted as equivalent facilities. [4]

A useful local supply map records unique doctors, practice hours, hospital affiliations, maternity capability, emergency and referral access, and the verified category of each fertility facility. Public provision and general practitioners should be included when examining access, even if the commercial project focuses on private specialists.

Cloudnine Fertility, Motherhood and Rainbow/BirthRight illustrate organized fertility and women-and-children care models. Their service descriptions help identify local alternatives. This report does not infer market shares from their websites or carry forward undated centre counts and merger claims. [10] [11] [12]

Use cities as a shortlist, then investigate the catchment.

State and city decisions require local evidence on age distribution, household affordability, existing services, travel time, public provision and clinician availability. A metro location may support a different fee and service mix from a district practice, but city tier alone does not establish demand, profitability or search volume.

The 20 catchments below are an illustrative research shortlist, not a ranked league table. No primary clinic census or paid keyword study was conducted for this publication.

Match each care pathway to its actual staffing, facilities and follow-up.

The commercial distinctions below concern service design. The investigations, visit frequency and treatment required by an individual remain clinical decisions. A higher-priced procedure or a longer course of care should not become an acquisition target regardless of suitability.

A transparent quotation is more useful than an unsupported national price range.

Directory fees and advertised packages vary by clinician, location, date, facilities and inclusions. A consultation price does not indicate an entire pregnancy episode or IVF cycle cost. This edition does not present unverified city-wide price bands as observed benchmarks.

For local research, collect comparable written quotations: consultation and follow-up terms; investigations; clinician and hospital fees; medicines; anesthesia and procedures where relevant; laboratory services; storage; optional components; cancellations; and contingencies. Record the date and whether the figures are estimates, package prices or actual invoices.

For example, a hypothetical fertility budget with a ₹1,80,000 procedure component, ₹60,000 medication allowance and ₹20,000 storage or other specified services totals ₹2,60,000. Each input is an assumption. It demonstrates inclusion accounting, not a recommended treatment plan or a current provider price. Avoid adding items already included in the package.

Calculate collections from attended visits before estimating profit.

The following scenarios assume 26 working days per month and the same activity for 12 months. Each billed encounter is counted once. Average collection is money received per encounter; the scenarios exclude separately billed delivery admissions, surgery and IVF cycles.

Monthly collections = attended encounters per day × working days × average collection per encounter. The output changes directly with activity and collection assumptions. These examples do not establish typical clinic footfall.

Track the patient journey without confusing total spending with clinic income.

A pregnancy episode may involve consultation visits, investigations, a delivery admission and postnatal services delivered by different organizations. Attribute revenue only to the provider that earns it. Public services, insurance, affordability and clinical needs also influence the pathway.

In an illustrative accounting example, eight consultations at ₹900 and two follow-up consultations at ₹900 produce ₹9,000 of consultation collections. If external diagnostics and a hospital admission are billed separately, their revenue does not belong to the clinic. The number of visits is an arithmetic input, not a care recommendation.

Delivery method should be clinically determined. A maternity financial plan should fund safe staffing, escalation arrangements and continuity of care, rather than treat a higher procedure rate as a growth objective. Record professional fees, hospital collections and facility costs separately when evaluating a practice with hospital attachments.

Potential need is broader than the market for IVF cycles.

WHO explains that infertility may involve male, female or unexplained factors. Its global lifetime estimate is approximately one in six people of reproductive age; this is not an India-specific count of women who require IVF. [8] Local demand also depends on diagnosis, clinical suitability, access, affordability and patients’ preferences.

Fertility consultations, investigations, laboratory procedures and treatment cycles should be recorded separately. A consultation does not guarantee treatment, and a treatment cycle does not guarantee pregnancy or live birth. Repeat-cycle assumptions should never be used to promise a clinic an automatic patient lifetime value.

For a facility scenario, 15 completed, separately billed cycles at an assumed ₹1,80,000 each yield ₹27 lakh of gross cycle collections. This excludes direct laboratory, medication, clinician, staffing and capital costs. It is neither profit nor an operating benchmark. Consultations included in those packages cannot also be counted in the outpatient table.

Evaluate marketing using attended consultations and subsequent appropriately agreed care, with clear attribution windows and outcome definitions. Any published clinical success figure needs a documented denominator, period and patient group.

Continuity of appropriate care is the service opportunity.

WHO’s January 2026 fact sheet estimates that PCOS affects 10–13% of reproductive-aged women globally and describes it as a chronic metabolic condition. Diagnostic criteria and study populations matter; the global percentage should not be multiplied by an uncertain India population denominator to claim a precise national caseload. [6]

A clinic’s digital information should explain who provides assessment, how relevant disciplines coordinate and how follow-up is arranged. Education and access can support informed decisions. Claims about curing PCOS, guaranteed weight loss or universal treatment packages require scrutiny.

For business planning, observe actual cohorts: clinically due follow-ups, realized collections, direct costs, patient experience and reasons for leaving care. Four hypothetical consultations at ₹900 produce ₹3,600 of annual consultation revenue, before costs. That calculation does not prescribe four visits or validate a multi-year lifetime-value claim.

A life-stage service needs clear scope and respectful communication.

WHO describes natural menopause as generally occurring between ages 45 and 55 worldwide and emphasizes support across physical, psychological and social needs. [7] This age range cannot establish how many Indian women enter menopause each year; the size of an age group and annual transitions are different quantities.

Practices can assess whether their catchment needs better information and access to menopause consultations, counselling and appropriate referrals. Publish verified clinician capabilities and a clear service scope. Avoid treating every symptom as an indication for a preset programme or implying that a wellness package is universally suitable.

Platform activity supports a local research question, not a nationwide demand forecast.

The NFHS-6 release reports that the share of women who had ever used the internet rose from 33.3% to 64.3%. This survey indicator does not measure healthcare searches or demand for paid care. [2]

Practo’s March 2025 report on 2024 activity says women aged 25–34 accounted for roughly 60% of gynecology consultations and tier-1 cities for 76% of gynecology consultations on its platform. These are platform-specific shares and should not be generalized to all women or all providers. [9]

Google’s local-ranking guidance emphasizes complete, accurate information and the roles of relevance, distance and prominence. [13] For a women’s clinic, review the name, location, hours, available clinicians, service descriptions, contact routes and appointment instructions. Accurate information helps patients judge fit and access.

Potential search themes include gynecologist or women’s clinic by locality, pregnancy care, fertility assessment, PCOS services and menopause consultations. These are themes to investigate, not measured search volumes or a ranking of profitable keywords. Referral, phone and walk-in activity should be assessed alongside search.

To quantify digital readiness, define a catchment, deduplicate listings and inspect a consistent sample for website access, credentials, service clarity, current timings and working appointment links. Record what was actually observed. No percentage of clinics needing a website or optimization is asserted here.

Keep every conversion step visible.

This model assumes a ₹40 cost per click, 4% click-to-enquiry conversion, 50% enquiry-to-booking conversion and 85% booking attendance. All four inputs are hypothetical. Fractional outputs represent expected averages across repeated campaigns, not fractions of actual patients.

Make the next step understandable and easy to complete.

The website should make it easy to verify the doctor and service, understand where care is delivered, check timings and request an appointment. Relevant details include qualifications, languages, female-doctor availability where offered, hospital affiliations, accessibility, consultation charges or quotation terms, and what happens after an enquiry.

Give pregnancy, fertility, PCOS and menopause distinct service pages when the practice actually offers those services. Each page should answer the patient’s likely access questions and offer a simple contact route. Reviews, photos and educational material should accurately represent the clinic.

Scope the work around the clinic’s current bottleneck.

Start with reliable public information and appointment access. Add measurement and follow-up once the team can own the process. Expand content or paid acquisition where the practice has capacity and can evaluate results. The budget ranges below are illustrative planning envelopes, not observed industry averages or Nousdoc price quotations.

State whether media spend, third-party software, hosting, content production and ongoing support are included in a service quote. Compare agencies using scope, evidence and actual total cost. A low setup price with undefined support can be hard to compare with a managed service.

Protect the enquiry while making access easier.

For appointment enquiries, request only what the team needs to arrange contact. Keep clinical histories and reports out of marketing analytics and advertising systems. Use an appropriate clinical channel for sensitive information, and separate care-related communications from promotional messaging.

Google restricts personalized advertising involving sensitive health categories. [14] Fertility, pregnancy and condition-related campaigns need policy review before using audience lists or remarketing. Patient health information and consent to clinical contact should not be treated as unrestricted advertising permission.

Check facility registration against the appropriate official records and have the responsible clinical team review service descriptions and outcome claims. [4] Avoid promises of pregnancy or treatment success. Reviews and patient stories must protect confidentiality, with suitable permission for any identifiable material. This is an operational planning framework, not a determination of legal compliance.

Choose a specialty using measured delivery economics and service capability.

Dental, pediatric and women’s health practices have different care pathways. Within women’s health alone, a routine consultation, a delivery admission and IVF involve different facilities, costs, risks and decision periods. Comparing their invoice values without those differences can overstate the attractiveness of a niche.

A digital-services business should evaluate access to prospective clients, delivery effort, realistic client budgets, enquiry quality, follow-up ownership and incremental contribution after acquisition costs. Gynecology is a candidate segment to validate; the sources reviewed do not establish that it universally outperforms dentistry, pediatrics or dermatology.

Use definitions that distinguish access, service quality and financial performance.

Build a baseline before setting targets. Segment reporting by care pathway and compare similar periods. Clinically necessary follow-up and appropriate treatment should determine care activity; a dashboard should not reward unnecessary visits or procedures.

Use this synthesis to design a local pilot.

This desk-research edition adapts the supplied market report using sources reviewed on 21 September 2026. It combines dated official indicators, provider descriptions, platform observations and attributed commercial estimates. It does not include a representative clinic survey, live ad-account data or a city-level provider census.

Female population uses the World Bank series. The maternity comparison uses the May 2026 NFHS-6 release. FOGSI membership is explicitly historical. ART registration categories are kept separate. Global clinical prevalence is not converted into an India-specific customer count. Treatment-cost and revenue examples show assumptions rather than assert national tariffs or profit margins.

For a practical next step, select three to five catchments, verify a sample of providers and compare service access, current fees and website quality. Interview clinic owners, agree a measurable scope and run a bounded pilot. Use observed attendance, collections, delivery costs and patient experience to decide whether expansion is justified.

What can this report support today?

How large is the opportunity?

There is a large population context and documented demand for women’s healthcare. A particular clinic or agency still needs catchment-level evidence. The report does not claim a verified total number of active gynecologists, independent women’s clinics or operating IVF laboratories.

Which services should a digital team improve first?

Start with correct clinic information, verified clinician profiles, clear service pages, appointment access and response ownership. Use actual bottlenecks to decide whether content, reminders, integrations or advertising should follow.

Can the financial examples predict returns?

They show how assumptions connect. Replace them with measured conversion rates, collected fees and care-delivery costs before forecasting. Neither higher spend nor higher-priced treatment guarantees better returns.

Linked sources and their scope.

1. World Bank: Population, female — India

   Indicator SP.POP.TOTL.FE.IN, based on UN population estimates. The API returned 702,612,364 for 2024 and 709,090,076 for 2025 when reviewed on 21 September 2026.

   Reference 1
2. Ministry of Health and Family Welfare: release of NFHS-6

   Official release dated 29 May 2026. Survey period: 2023–24, compared with NFHS-5 (2019–21). Supports the maternity and digital-use indicators cited here.

   Reference 2
3. FOGSI: Secretary General’s message

   Historical membership disclosure: 39,607 in December 2022. Association membership is not a census of currently active private specialists.

   Reference 3
4. Department of Health Research: National ART & Surrogacy Registry

   Describes the official public-record system for ART clinics, banks and surrogacy clinics. Categories and registration status must be distinguished in any count.

   Reference 4
5. TechSci Research: India in-vitro fertilization market outlook

   Commercial estimate of US$961.21 million for 2024 and forecast of US$1,491.85 million for 2030. Publisher estimate and forecast, not official national accounts.

   Reference 5
6. WHO: Polycystic ovary syndrome

   January 2026 fact sheet; global prevalence estimate and clinical context. It does not establish an India-specific patient count.

   Reference 6
7. WHO: Menopause

   Global life-stage context, usual age range and support needs. Not an estimate of annual menopause transitions in India.

   Reference 7
8. WHO: Infertility

   November 2025 fact sheet. Infertility may involve male, female or unexplained factors; population need is distinct from demand for IVF.

   Reference 8
9. Practo: Millennial women drive rise in gynecology consultations

   Published 6 March 2025 and describes platform activity in 2024. Its age, city and specialty shares do not describe all Indian patients.

   Reference 9
10. Cloudnine Fertility: IVF services

    Provider description of fertility services and appointment access; not a national cost or success-rate benchmark.

    Reference 10
11. Motherhood Hospitals: official website

    Provider-reported women’s, maternity and child-care services and appointment channels.

    Reference 11
12. Rainbow Hospitals and BirthRight: official website

    Provider-reported women’s, maternity, fertility and pediatric services. No network-size or market-share inference is made.

    Reference 12
13. Google Business Profile Help: improve local ranking

    Official guidance on accurate business information and relevance, distance and prominence.

    Reference 13
14. Google Ads policy: health in personalised advertising

    Official restrictions concerning sensitive health categories and audience use. Campaign eligibility depends on current policy and configuration.

    Reference 14